Alyeska Investment Group’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50,000	Closed	-$770K	–	877
2021 Q1	$770K	Buy	+50,000	New	+$770K	0.01%	611